EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Endomyocardial biopsy

Enrico Fabris, Aldostefano Porcari, Rossana Bussani, Maurizio Pinamonti, Marco Merlo, Serena Rakar, Andrea Perkan, Jozef Bartunek, Gianfranco Sinagra

EuroIntervention · 2026

DOI: 10.4244/eij-d-25-00263 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift EuroIntervention, 2026. Verfasst von Enrico Fabris und 8 weiteren Autor:innen. Beteiligte Einrichtung: Interventional Cardiology Unit, Cardiothoracovascular Department, University of Trieste, Trieste, Italy. Hauptthemen laut MEDLINE: Myocardium, Cardiomyopathies, Myocarditis, Endocardium. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endomyocardial biopsy (EMB) has evolved from a single-indication test for the early diagnosis and monitoring of heart transplant rejection to the gold-standard technique to reach a definite and aetiological diagnosis in different cardiac disorders such as myocarditis and cardiomyopathies. It is currently considered a fundamental tool in the diagnostic workup of unexplained acute heart failure with haemodynamic compromise. For interventional cardiologists, EMB represents a unique opportunity to bridge invasive diagnostics with personalised care. By embracing technological advancements, integrating EMB with non-invasive modalities, the field advances towards more precise and effective management of complex cardiac conditions. However, safety remains a concern when performing EMB; indeed, although rare, major complications occur in about 1-5% of cases. Correct indication for the procedure and specific expertise to minimise the risk of complications are fundamental to obtain an acceptable risk/benefit profile. Therefore, this review examines the contemporary use of EMB from the perspective of interventional cardiologists to provide a practical resource for clinical practice and to better understand when and how to perform both right and left ventricular EMB in current practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyocardiumCardiomyopathiesMyocarditisEndocardiumHeart FailureHumansBiopsyHeart Transplantation

Autor:innen und Institutionen

  • Interventional Cardiology Unit, Cardiothoracovascular Department, University of Trieste, Trieste, Italy.
  • Center for Diagnosis and Treatment of Cardiomyopathies, Cardiothoracovascular Department, University of Trieste, Trieste, Italy.
  • National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom.
  • Institute of Pathological Anatomy and Histology, University of Trieste, Trieste, Italy.
  • Cardiovascular Center, AZORG, Aalst, Belgium.
  • European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart, ERN GUARD-Heart, Trieste, Italy.

Zitieren

APA

Fabris, E., Porcari, A., Bussani, R., Pinamonti, M., Merlo, M., Rakar, S., Perkan, A., Bartunek, J., & Sinagra, G. (2026). Endomyocardial biopsy. EuroIntervention. https://doi.org/10.4244/eij-d-25-00263

Vancouver

Fabris E, Porcari A, Bussani R, Pinamonti M, Merlo M, Rakar S, et al. Endomyocardial biopsy. EuroIntervention. 2026. doi:10.4244/eij-d-25-00263

BibTeX
@article{Fabris2026,
  author = {Fabris, Enrico and Porcari, Aldostefano and Bussani, Rossana and Pinamonti, Maurizio and Merlo, Marco and Rakar, Serena and Perkan, Andrea and Bartunek, Jozef and Sinagra, Gianfranco},
  title = {Endomyocardial biopsy},
  journal = {EuroIntervention},
  year = {2026},
  doi = {10.4244/eij-d-25-00263}
}
Kostenlos starten →